Table 1.
Distribution of study participants by demographic characteristics.
| Study cohort | AFIRM | KMLC | ||||
|---|---|---|---|---|---|---|
| Study location | Junju | Ngerenya | Junju | |||
| Sub-group | NA | Early | Late | NA | ||
| Duration of study | May–Dec 2014 | Jan–Apr 2014 | 1998–2001 | 2002–2016* | 2007–2016 | |
| Season | Wet | Dry | NA | NA | NA | |
| Number of Participants | 274 | 139† | 50 | 127 | 97 | |
| Age (in years) %, (n/N) | ||||||
| <5 | 24.1% (66/274) | 11.5% (16/139) | 48.0% (24/50) | 42.5% (54/127) | 41.2% (40/97) | |
| 5–9 | 13.5% (37/274) | 10.8% (15/139) | 42.0% (21/50) | 42.5% (54/127) | 39.2% (38/97) | |
| 10–15 | 14.2% (39/274) | 12.9% (18/139) | 10.0% (5/50) | 15.0% (19/127) | 19.6% (19/97) | |
| >15 | 48.2% 132/274 | 64.8% (90/139) | NA | NA | NA | |
| Gender, % Female (n/N) | 60.5% (166/274) | 31.0% (96/139) | 50.0% (25/50) | 31.5% (40/127) | 67.0% (65/97) | |
| Asexual parasite positive % (n/N) | ||||||
| Microscopy | 17.2% (47/274) | 6.5% (9/139) | 78.0% (39/50) | 18.7% (24/127) | 59.8% (58/97) | |
| 18s QT NASBA |
50.4% (138/274) | 35.3% (49/139) | NA | NA | NA | |
| Gametocyte positive % (n/N) | ||||||
| Microscopy | 2.2% (6/274) | 1.4% (2/139) | 50.0% (25/50) | 6.3% (8/127) | 35.1% (34/97) | |
| Pfs25 QT NASBA | 29.6% (81/274) | 17.9% (25/139) | NA | NA | NA | |
†35 participants recruited in January–February 2015; *no cross-sectional survey conducted in 2006; NA refers to not applicable.